REFERENCES
- Towner S R, Michet C J, jr, O'Fallon W M. The epidemiology of juvenile rheumatoid arthritis in Rochester, Minnesota. Arthritis Rheum. 1983; 26: 1208, [PUBMED], [INFOTRIEVE], [CSA]
- Cassidy J T, Petty R E. Textbook of Pediatric Rheumatology 3rd ed. W.B. Saunders, Philadelphia 1994
- Tugal-Tutkun I, Havrlikova K, Power W J, Foster C S. Changing patterns in uveitis of childhood. Ophthalmology. 1996; 103: 375–383, [PUBMED], [INFOTRIEVE], [CSA]
- Wolf M D, Lichter M D, Ragsdale C G. Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology. 1987; 94: 1242–1248, [PUBMED], [INFOTRIEVE], [CSA]
- Kanski J J. Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis. Eye. 1988; 2: 641–645, [PUBMED], [INFOTRIEVE], [CSA]
- Spalter H F. The visual prognosis in juvenile rheumatoid arthritis. Trans Am Ophthalmol Soc. 1975; 73: 554–570, [PUBMED], [INFOTRIEVE], [CSA]
- Key S N, iii, Kimura S J. Iridocyclitis associated with juvenile rheumatoid arthritis. Am J Ophthalmol. 1975; 80: 425–429, [PUBMED], [INFOTRIEVE], [CSA]
- Dana M R, Merayo-Lloves J, Schaumberg D A. et al. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997; 104: 236–244, [PUBMED], [INFOTRIEVE], [CSA]
- Cassidy J T, Levinson J E, Bass J C, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986; 29: 274–281, [PUBMED], [INFOTRIEVE], [CSA]
- Foster C S, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993; 100: 809–817, [PUBMED], [INFOTRIEVE], [CSA]
- van Staa T P, Leufkens H G, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002; 13(10)777–787, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Lard L R, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med. 2001; 111: 446–451, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Borg G, Allander E, Lund B, et al. Auranofin improves outcome in early rheumatoid arthritis: results from a 2-year, double-blind placebo controlled study. J Rheumatol. 1988; 15: 1747–1754, [PUBMED], [INFOTRIEVE], [CSA]
- van d erHeijde D M, Jacobs J W, Bijlsma J W, et al. The effectiveness of early treatment with ‘second-line’ antirheumatic drugs: a randomized, controlled trial. Ann Intern Med. 1996; 124: 699–707, [CSA]
- Giannini E H, Brewer E J, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.–U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med. 1992; 326(16)1043–1049, [PUBMED], [INFOTRIEVE], [CSA]
- Rose C D, Singsen B H, Eichenfield A H, et al. Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1990; 117(4)653–659, [PUBMED], [INFOTRIEVE], [CSA]
- Shetty A K, Zganjar B E, Ellis G S, jr, et al. Low-dose methotrexate in the treatment of severe juvenile rheumatoid arthritis and sarcoid iritis. J Pediatr Ophthalmol Strabismus. 1999; 36(3)125–128, [PUBMED], [INFOTRIEVE], [CSA]
- Weiss A H, Wallace C A, Sherry D D. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr. 1998; 133(2)266–268, [PUBMED], [INFOTRIEVE], [CSA]
- Samson C M, Waheed N, Foster C S. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology. 2001; 108(6)1134–1139, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Foster C S, Tufail F, Waheed N K, Chu D, Miserocchi E, Baltatzis S, Vredeveld C M. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol. 2003; 121: 437–440, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Edelsten C, Lee V, Bentley C R, Kanski J J, Graham E M. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002; 86: 51–56, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Özdal P C, Vianna R NG, Deschênes J. Visual outcome of juvenile rheumatoid arthritis associated uveitis in adults. Ocul Immunol Inflamm. 2005; 13(1)33–38, [CSA], [CROSSREF], [CROSSREF]
- Sherry D D, Mellins E D, Wedgwood R J. Decreasing severity of chronic uveitis in children with pauciarticular arthritis. Am J Dis Child. 1991; 145: 1026–1028, [PUBMED], [INFOTRIEVE], [CSA]
- Chalom E C, Goldsmith D P, Koehler M A, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol. 1997; 24: 2031–2034, [PUBMED], [INFOTRIEVE], [CSA]
- Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology. 2001; 108: 2071–2075, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Rosenberg K, Feuer, Davis J L. Ocular complications of pediatric uveitis. Ophthalmology. 2004; 111: 2299–2306, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Zak M, Fledelius H, Pedersen F K. Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study. Acta Ophthalmol Scand. 2003; 81: 211–215, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]